Seladelpar

1 Drug classified under this active ingredient

peroxisome proliferator-activated receptor delta (PPARδ) agonist. Seladelpar 10 mg.
Caps: 30 X 10 mg
Recomm. dose: 10 mg once daily.
For prim. biliary cholangitis (PBC) in combin. with ursodeoxycholic acid (UDCA) in adlts who have an inadequate resp. to UDCA alone, or as monother. in those unable to toler. UDCA.
C/I: Hypersens.